drugset / Trial / NCT06732466

Evaluation of the Effect of a Toothpaste Containing 0.3% Chlorhexidine in Subjects With Established Dental Plaque and Gingivitis

NCT06732466

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase III, one-center, parallel group, double blind, clinical study to evaluate the effect of a toothpaste containing 0.3% chlorhexidine in subjects with established dental plaque and gingivitis. It involves 80 participants aged between 18 and 70, randomly assigned to different groups, and spans 21 days.

Timeline

Start
2025-03-24
Primary completion
2025-04-15
Completion
2025-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject AmCl Unknown 3 %
Subject Chlorhexidine Small molecule 0.3 %